Document Detail

Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension.
MedLine Citation:
PMID:  17308944     Owner:  NLM     Status:  MEDLINE    
Microalbuminuria (MA) is associated with increased cardiovascular risk in adult hypertensive patients, but no study has specifically examined the effects of MA lowering on regression of left ventricular hypertrophy (LVH) among pediatric patients with hypertension. Fifty-five patients with essential hypertension, 11-19 years old, were prospectively studied. All patients received concomitant therapy of hydrochlorothiazide and angiotensin-converting enzyme inhibitor. Five patients also required angiotensin receptor blocker to achieve the blood pressure goal. Baseline and 12-month follow-up measures of left ventricular mass index (LVMI), determined by echocardiography and urine microalbumin/creatinine ratio (MA/Cr), were collected. MA was defined as MA/Cr >30 microg/mg. LVH was defined as LVMI >38.6 g/m(2.7). The primary end points were reductions in MA and LVMI of 25% or more. Weight (r = 0.83), body surface area (r = 0.85), body mass index (BMI) (r = 0.86), systolic blood pressure (SBP) (r = 0.57), diastolic blood pressure (DBF) (r = 0.49), mean arterial pressure (r = 0.53) and MA (r= 0.87) were all univariate correlates of LVMI. In a multiple regression analysis, MA, BMI and SBP were significant correlates of LVMI. MA alone explained 76% of the variance of LVMI, whereas BMI and SBP explained only 1.6 and 0.4% of the variance, respectively. MA was the most significant correlate of follow-up LVMI after BMI and SBP were included in the overall multiple regression models. Thus, MA is a strong predictor of LVH in hypertensive children and adolescents. MA lowering halts the progression of LVH or induces its regression.
Farahnak Assadi
Related Documents :
19478224 - Stroke risk of blood pressure indices determined by home blood pressure measurement: th...
15302984 - Relationship between sleep-disordered breathing and blood pressure levels in community-...
3046884 - Efficacy and tolerance of cicletanine, a new antihypertensive agent: overview of 1226 t...
9546944 - Effect of felodipine on regional blood supply and collateral vascular resistance in pat...
16638254 - Assessing blood pressure control in patients treated for hypertension: comparing differ...
9891634 - Mechanical ventilation of patients with acute lung injury.
Publication Detail:
Type:  Clinical Trial; Journal Article     Date:  2007-02-16
Journal Detail:
Title:  Pediatric cardiology     Volume:  28     ISSN:  0172-0643     ISO Abbreviation:  Pediatr Cardiol     Publication Date:    2007 Jan-Feb
Date Detail:
Created Date:  2007-02-23     Completed Date:  2007-05-08     Revised Date:  2008-02-20    
Medline Journal Info:
Nlm Unique ID:  8003849     Medline TA:  Pediatr Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  27-33     Citation Subset:  IM    
Rush Children's Hospital, 1725 West Harrison Street, Professional Building, Suite 710, Chicago, IL 60612, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Age Factors
Albuminuria / drug therapy,  prevention & control*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Antihypertensive Agents / therapeutic use*
Blood Pressure / drug effects
Disease Progression
Hypertension / complications,  drug therapy,  physiopathology*
Hypertrophy, Left Ventricular / etiology,  physiopathology*
Prospective Studies
Risk Factors
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The modified Blalock-Taussig shunt versus the right ventricle-to-pulmonary artery conduit for the No...
Next Document:  Endothelial dysfunction and circadian blood pressure rhythmicity in young heart transplant recipient...